.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Express Scripts
Medtronic
Dow
QuintilesIMS
McKinsey
US Army
AstraZeneca
Federal Trade Commission

Generated: July 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019901

« Back to Dashboard
NDA 019901 describes ALTACE, which is a drug marketed by King Pharms and King Pfizer and is included in two NDAs. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the ALTACE profile page.

The generic ingredient in ALTACE is ramipril. There are nineteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the ramipril profile page.

Summary for NDA: 019901

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 019901

Suppliers and Packaging for NDA: 019901

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALTACE
ramipril
CAPSULE;ORAL 019901 NDA Pfizer Laboratories Div Pfizer Inc 61570-110 61570-110-01 100 CAPSULE in 1 BOTTLE (61570-110-01)
ALTACE
ramipril
CAPSULE;ORAL 019901 NDA Pfizer Laboratories Div Pfizer Inc 61570-111 61570-111-01 100 CAPSULE in 1 BOTTLE (61570-111-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength1.25MG
Approval Date:Jan 28, 1991TE:ABRLD:Yes
Patent:7,368,469Patent Expiration:Aug 30, 2020Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD OF REDUCING RISK OF MYOCARDIAL INFARCTION, STROKE AND DEATH

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength2.5MG
Approval Date:Jan 28, 1991TE:ABRLD:Yes
Patent:7,368,469Patent Expiration:Aug 30, 2020Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD OF REDUCING RISK OF MYOCARDIAL INFARCTION, STROKE AND DEATH

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength5MG
Approval Date:Jan 28, 1991TE:ABRLD:Yes
Patent:7,368,469Patent Expiration:Aug 30, 2020Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD OF REDUCING RISK OF MYOCARDIAL INFARCTION, STROKE AND DEATH

Expired Orange Book Patents for NDA: 019901

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms
ALTACE
ramipril
CAPSULE;ORAL019901-004Jan 28, 19915,403,856► Subscribe
King Pharms
ALTACE
ramipril
CAPSULE;ORAL019901-002Jan 28, 19915,061,722► Subscribe
King Pharms
ALTACE
ramipril
CAPSULE;ORAL019901-002Jan 28, 19915,403,856► Subscribe
King Pharms
ALTACE
ramipril
CAPSULE;ORAL019901-001Jan 28, 19914,587,258► Subscribe
King Pharms
ALTACE
ramipril
CAPSULE;ORAL019901-003Jan 28, 19914,587,258► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
AstraZeneca
Farmers Insurance
Baxter
Cerilliant
Dow
Moodys
McKesson
Queensland Health
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot